<DOC>
	<DOCNO>NCT02347618</DOCNO>
	<brief_summary>The purpose study determine whether short-course stereotactic body radiotherapy ( SBRT ) prior surgical resection pancreatic adenocarcinoma feasible well-tolerated .</brief_summary>
	<brief_title>Pilot Study Short-Course Preoperative Stereotactic Body Radiation Therapy Resectable Pancreatic Cancer</brief_title>
	<detailed_description>This Phase 2 , single center , prospective , single arm feasibility study use stereotactic body radiotherapy ( SBRT ) preoperative treatment surgically resectable pancreatic adenocarcinoma .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>1 . Patient pathologically proven diagnosis adenocarcinoma head pancreas 2 . CT w/ contrast use pancreas protocol MRI abdomen contrast within 6 week prior registration 3 . CT chest PET/CT within 6 week prior registration 4 . Clinically determine resectable base NCCN Criteria : 5 . No radiographic evidence superior mesenteric vein portal vein distortion 6 . No evidence distant metastasis 7 . Clear fat plane around celiac axis , hepatic artery , superior mesenteric artery 8 . No enlarged lymph node per CT criterion PET avid lymph node 9 . No lymphadenopathy outside surgical field ( i.e . celiac paraaortic adenopathy ) 10 . Adequate cardiopulmonary reserve tolerate surgery 11 . Karnofsky performance status &gt; 70 12 . Age &gt; 18 13 . Adequate bone marrow function define follow : 14 . Absolute neutrophil count ( ANC ) &gt; 1800 cells/mm3 15 . Platelets â‰¥ 100,000 cells/mm3 16 . Hemoglobin &gt; 8.0 g/dl ( Note : The use transfusion intervention achieve Hgb &gt; 8 g/dl acceptable . ) 17 . Pregnancy test must negative woman childbearing potential within 7 day prior study entry 18 . Patient must sign study specific informed consent prior study entry 1 . Prior surgical resection pancreatic malignancy 2 . Prior invasive malignancy ( except nonmelanomatous skin cancer ) unless disease free minimum 3 year 3 . Any prior chemotherapy radiation treatment patient 's pancreatic tumor . 4 . Prior radiotherapy region study cancer would result overlap radiation therapy field 5 . Severe , active comorbidity , define follow : 1 . Unstable angina and/or congestive heart failure require hospitalization within last 12 month 2 . Transmural myocardial infarction within last 6 month 3 . Acute bacterial fungal infection require intravenous antibiotic time registration 4 . Chronic obstructive pulmonary disease exacerbation respiratory illness require hospitalization preclude study therapy within 30 day prior registration . 6 . Severe , uncorrectable hepatic insufficiency and/or coagulation defect due liver failure 7 . Any evidence distant metastasis ( M1 ) 8 . Pregnancy woman childbearing potential men sexually active willing/able use medically acceptable form contraception ; exclusion necessary treatment involve study may significantly teratogenic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>